Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margaux Bessou

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Oncogene|February 19, 2020
The apoptosis inhibitor Bcl-xL controls breast cancer cell migration through mitochondria-dependent reactive oxygen species productionMargaux Bessou, Jonathan Lopez, Rudy Gadet, et al.
Nature Communications|February 3, 2016
Mito-priming as a method to engineer Bcl-2 addictionJonathan Lopez, Margaux Bessou, Joel S Riley, et al.
Nature Communications|October 26, 2017
BCL-X<sub>L</sub> directly modulates RAS signalling to favour cancer cell stemnessSophie de Carné Trécesson, Frédérique Souazé, Agnès Basseville, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Oncogene|February 19, 2020
The apoptosis inhibitor Bcl-xL controls breast cancer cell migration through mitochondria-dependent reactive oxygen species productionMargaux Bessou, Jonathan Lopez, Rudy Gadet, et al.
Nature Communications|February 3, 2016
Mito-priming as a method to engineer Bcl-2 addictionJonathan Lopez, Margaux Bessou, Joel S Riley, et al.
Nature Communications|October 26, 2017
BCL-X<sub>L</sub> directly modulates RAS signalling to favour cancer cell stemnessSophie de Carné Trécesson, Frédérique Souazé, Agnès Basseville, et al.
Pageof 1